Influvac

Influvac Description

vaccine, influenza

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Influvac complies with the World Health Organization (southern hemisphere) and competent authority decision for the 2008 season.
For the 2008 season, 1 inoculation dose of 0.5 mL on the basis of these recommendations contains influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains*: A/Brisbane/10/2007 (H3N2)-like strain (A/Brisbane/10/2007 IVR-147 reass.) 15 mcg HA**, A/Solomon Islands/3/2006 (H1N1)-like strain (A/Solomon Islands/3/2006 IVR-145 reass.) 15 mcg HA**, B/Florida/4/2006-like strain, (B/Brisbane/3/2007) 15 mcg HA**.
*Propagated in fertilised hens' eggs from healthy chicken flocks.
**Haemagglutinin
Influvac also contains the following excipients: Potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, sodium chloride, calcium chloride, magnesium chloride hexahydrate and water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in